My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Actuate Therapeutics, Inc. - Common stock
(NQ:
ACTU
)
6.690
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Actuate Therapeutics, Inc. - Common stock
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer
September 22, 2025
Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026.
Via
Stocktwits
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 09, 2025
Via
Benzinga
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
August 26, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 27, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 26, 2025
Via
Benzinga
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
January 28, 2025
Via
Benzinga
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
December 13, 2024
Via
Benzinga
Pheton, Powell Max Make Public Debut
September 08, 2024
Pheton Holdings and Powell Max opened for trading on Thursday at $3.76 and $4.30, respectively. While the number of initial public offerings has rebounded from 2023, IPOs remain well below pre-pandemic...
Via
Talk Markets
Actuate Therapeutics Makes Public Debut
August 18, 2024
Actuate Therapeutics opened on Aug. 13 at $9.88. The biopharmaceutical company had priced its initial public offering of 2.8 million shares at a price of $8.00 per share.
Via
Talk Markets
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.